Uri Ladabaum

Publication Details

  • Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.

    Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U. Clin Gastroenterol Hepatol. 2005; 3 (1): 75-84

    HCV-related cirrhosis is a leading risk factor for hepatocellular carcinoma (HCC). Surveillance might detect HCC at a treatable stage. We estimated the clinical and economic consequences of a common HCC surveillance strategy in patients with HCV-related cirrhosis in the context of alternative HCC treatment strategies.

    PubMedID: 15645408

Stanford Medicine Resources:

Footer Links: